India · Delayed Price · Currency is INR NSE:STARHEALTH Statistics
Total Valuation
NSE:STARHEALTH has a market cap or net worth of INR 354.68 billion. The enterprise value is 356.89 billion.
| Market Cap | 354.68B |
| Enterprise Value | 356.89B |
Important Dates
The next confirmed earnings date is Wednesday, July 29, 2026.
| Earnings Date | Jul 29, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
NSE:STARHEALTH has 587.95 million shares outstanding. The number of shares has decreased by -1.10% in one year.
| Current Share Class | 587.95M |
| Shares Outstanding | 587.95M |
| Shares Change (YoY) | -1.10% |
| Shares Change (QoQ) | +0.16% |
| Owned by Insiders (%) | 16.12% |
| Owned by Institutions (%) | 28.49% |
| Float | 170.17M |
Valuation Ratios
The trailing PE ratio is 63.70 and the forward PE ratio is 33.99. NSE:STARHEALTH's PEG ratio is 1.25.
| PE Ratio | 63.70 |
| Forward PE | 33.99 |
| PS Ratio | 1.99 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | 1.25 |
Enterprise Valuation
| EV / Earnings | 64.08 |
| EV / Sales | 2.00 |
| EV / EBITDA | 45.50 |
| EV / EBIT | 47.38 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | 5.37% |
| Revenue Per Employee | 12.23M |
| Profits Per Employee | 381,885 |
| Employee Count | 14,585 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, NSE:STARHEALTH has paid 1.97 billion in taxes.
| Income Tax | 1.97B |
| Effective Tax Rate | 26.16% |
Stock Price Statistics
The stock price has increased by +39.30% in the last 52 weeks. The beta is 0.20, so NSE:STARHEALTH's price volatility has been lower than the market average.
| Beta (5Y) | 0.20 |
| 52-Week Price Change | +39.30% |
| 50-Day Moving Average | 541.54 |
| 200-Day Moving Average | 487.64 |
| Relative Strength Index (RSI) | 72.48 |
| Average Volume (20 Days) | 1,000,612 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:STARHEALTH had revenue of INR 178.33 billion and earned 5.57 billion in profits. Earnings per share was 9.47.
| Revenue | 178.33B |
| Gross Profit | 37.85B |
| Operating Income | 7.53B |
| Pretax Income | 7.54B |
| Net Income | 5.57B |
| EBITDA | 7.84B |
| EBIT | 7.53B |
| Earnings Per Share (EPS) | 9.47 |
Balance Sheet
| Cash & Cash Equivalents | n/a |
| Total Debt | n/a |
| Net Cash | n/a |
| Net Cash Per Share | n/a |
| Equity (Book Value) | n/a |
| Book Value Per Share | n/a |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 21.22%, with operating and profit margins of 4.22% and 3.12%.
| Gross Margin | 21.22% |
| Operating Margin | 4.22% |
| Pretax Margin | 4.23% |
| Profit Margin | 3.12% |
| EBITDA Margin | 4.40% |
| EBIT Margin | 4.22% |
| FCF Margin | n/a |
Dividends & Yields
NSE:STARHEALTH does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 1.10% |
| Shareholder Yield | 1.10% |
| Earnings Yield | 1.57% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | n/a |
| Graham Upside | n/a |
Analyst Forecast
The average price target for NSE:STARHEALTH is 589.21, which is -2.12% lower than the current price. The consensus rating is "Buy".
| Price Target | 589.21 |
| Price Target Difference | -2.12% |
| Analyst Consensus | Buy |
| Analyst Count | 23 |
| Revenue Growth Forecast (3Y) | 14.99% |
| EPS Growth Forecast (3Y) | 41.61% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |